Synthego nets $110 mln Series C


Silicon Valley-based Synthego, a genome engineering innovation company, has raised $110 million in Series C financing. Founders Fund led the round with participation from return backers 8VC and Menlo Ventures.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!